Cover art for Experimental Vaccine Extends Life in Severe Leukemia Cases

Experimental Vaccine Extends Life in Severe Leukemia Cases

Experimental leukemia vaccine boosts survival by over nine months for severe blood cancer patients.

By ·

Nov 20, 2026

4 cards · 50s · tap to begin

From · · · 50s

Experimental Vaccine Extends Life in Severe Leukemia Cases

Experimental leukemia vaccine boosts survival by over nine months for severe blood cancer patients.

In brief

Experimental leukemia vaccine boosts survival by over nine months for severe blood cancer patients. A new experimental vaccine for acute myeloid leukemia significantly increases median survival from 14.7 to 24 months in patients who completed chemotherapy. Originally reported by CNN Brasil.

Experimental Vaccine Boosts Survival

A new experimental vaccine for acute myeloid leukemia significantly increases median survival from 14.7 to 24 months in patients who completed chemotherapy.

How the Vaccine Works

The vaccine trains the patient's immune system to recognize and destroy residual cancer cells after chemotherapy.

Key Results of Study

Key Results of Study

The study showed a 41% reduction in mortality risk and a median survival of 24 months for patients receiving the vaccine.

Next Steps for Approval

SELLAS Life Sciences plans to discuss FDA approval pathways with the U.S. agency by early 2027.

The headline

A new experimental vaccine for acute myeloid leukemia significantly increases median survival from 14.7 to 24 months in patients who completed chemotherapy.

Read the original on CNN Brasil

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on leukemia and related topics.